Concerning the possible mechanisms responsible for survivin down-regulation after exposure to selinexor, it was previously shown that, in triple negative breast cancer cells, XPO1 inhibition represses survivin/BIRC5 transcription by inhibiting STAT3 acetylation and blocking STAT3 binding to the gene promoter [20]. This evidence concerns the gene XPO1 and triple-negative breast carcinoma.